Skip to main content

Peer Review reports

From: Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC

Original Submission
16 Jan 2024 Submitted Original manuscript
13 Feb 2024 Reviewed Reviewer Report
17 Feb 2024 Reviewed Reviewer Report
20 Mar 2024 Author responded Author comments - Pingli Wang
Resubmission - Version 2
20 Mar 2024 Submitted Manuscript version 2
23 Mar 2024 Reviewed Reviewer Report
15 Apr 2024 Author responded Author comments - Pingli Wang
Resubmission - Version 3
15 Apr 2024 Submitted Manuscript version 3
20 Apr 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
29 Apr 2024 Editorially accepted
23 May 2024 Article published 10.1186/s12890-024-03041-6

You can find further information about peer review here.

Back to article page